Filing Details

Accession Number:
0000891293-15-000037
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-25 16:42:32
Reporting Period:
2015-09-24
Filing Date:
2015-09-25
Accepted Time:
2015-09-25 16:42:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557551 Matthew Plunkett 3101 Western Avenue, Suite 600
Seattle WA 98121
Evp, Corporate Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-09-24 3,600 $1.52 797,353 No 4 S Direct
Common Stock Disposition 2015-09-24 13,201 $1.53 784,152 No 4 S Direct
Common Stock Disposition 2015-09-24 200 $1.53 783,952 No 4 S Direct
Common Stock Disposition 2015-09-24 6,899 $1.53 777,053 No 4 S Direct
Common Stock Disposition 2015-09-24 100 $1.54 776,953 No 4 S Direct
Common Stock Disposition 2015-09-24 289 $1.54 776,664 No 4 S Direct
Common Stock Disposition 2015-09-24 600 $1.55 776,064 No 4 S Direct
Common Stock Disposition 2015-09-24 800 $1.55 775,264 No 4 S Direct
Common Stock Disposition 2015-09-24 800 $1.56 774,464 No 4 S Direct
Common Stock Disposition 2015-09-24 1,700 $1.57 772,764 No 4 S Direct
Common Stock Disposition 2015-09-24 1,000 $1.58 771,764 No 4 S Direct
Common Stock Disposition 2015-09-24 5,330 $1.58 766,434 No 4 S Direct
Common Stock Disposition 2015-09-24 7,000 $1.59 759,434 No 4 S Direct
Common Stock Disposition 2015-09-24 16,400 $1.59 743,034 No 4 S Direct
Common Stock Disposition 2015-09-24 1,500 $1.60 741,534 No 4 S Direct
Common Stock Disposition 2015-09-24 14,400 $1.60 727,134 No 4 S Direct
Common Stock Disposition 2015-09-24 1,390 $1.61 725,744 No 4 S Direct
Common Stock Disposition 2015-09-24 660 $1.61 725,084 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale was effected pursuant to a Rule 10b5-1 trading plan.